markets.businessinsider.com/stocks/mallinckrodt-stock

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty ...

money.cnn.com/quote/forecast/forecast.html?symb=MNK

The 14 analysts offering 12-month price forecasts for Mallinckrodt Plc have a median target of 29.00, with a high estimate of 42.00 and a low estimate of 14.00.

www.nytimes.com/topic/company/mallinckrodt-plc

Mallinckrodt Plc. financial and business news, updates, and information from The New York Times and other leading providers.

www.law360.com/companies/mallinckrodt-plc

The latest litigation news, cases and dockets involving the company Mallinckrodt PLC (NYSE:MNK)

www.moodys.com/credit-ratings/Mallinckrodt-plc-credit-rating-823354783

Results 1 - 16 of 16 ... Moody's: FDA Proposal to withdraw generic Concerta from the market would be negative for Lannett and Mallinckrodt. Moody's Investors ...

quotes.wsj.com/MNK

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty ...

www.investors.com/news/technology/mallinckrodt-earnings-sales-top-estimates-mallinckrodt-stock-pops

Feb 26, 2019 ... Mallinckrodt earnings and sales crushed Wall Street's expectations in the fourth quarter, leading Mallinckrodt stock to ... Mallinckrodt Plc (MNK).

www.barchart.com/stocks/quotes/MNK

Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical ...

www.barrons.com/quote/stock/us/xnys/mnk

View the latest MNK stock price with Barron's. Including historical share prices, analysis, earnings, cash flow and market valuation for Mallinckrodt PLC.